VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMW 2019 | Immunotherapeutic approaches to myeloma

David Avigan, MD, Harvard Medical School, Boston, MA, gives an update on the immunotherapeutic approaches to multiple myeloma (MM) at the International Myeloma Workshop (IMW) 2019, held in Boston, MA. The most recent efficacy data on the use of CAR T-cells targetting BCMA for MM is discussed as is the use of bispecific antibodies, bispecific T-cell engagers (BiTEs), antibody-drug conjugates and vaccine therapies.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter